Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis

Table 2

Characteristics of the studies included in the C. pneumoniae IgG and IgA analysis.

First author	Year	Country	Cases	Number of cases	Number of controls	Study design	Serology assay
IgG
Nazmi [66]	2010	USA	CAD	697	288	Cross-sectional	MIF
Jitsuiki [60]	2006	Japan	A	136	123	Cross-sectional	ELISA
Adiloglu [57]	2005	Turkey	A	227	17	Case-control	ELISA
Zairis [54]	2003	Greece	SA, UA	182	214	Prospective	MIF
Altman [48]	2002	Argentina	CAD	107	52	Case-control	MIF
Schumacher [50]	2002	Norway	CAD	119	74	Cross-sectional	ELISA
Sander [47]	2001	Germany	TIA, IS	125	147	Prospective	MIF
IgA
Jha [65]	2009	India	CAD	155	37	Case-control	ELISA
Jitsuiki [60]	2006	Japan	A	92	167	Cross-sectional	ELISA
Schumacher [58]	2005	Norway	CAD	63	130	Cross-sectional	MIF
Gabriel [52]	2003	Sweden	CAD	38	15	Prospective	MIF
Zairis [54]	2003	Greece	SA, UA	87	214	Prospective	MIF
Toss [45]	1998	Sweden	UA	93	163	Prospective	MIF

CAD, coronary artery disease; A, atherosclerosis; SA, stable angina; UA, unstable angina; TIA, transient ischemic attack; IS, ischemic stroke.